Exogenous Flupirtine as Potential Treatment for CLN3 Disease
Article in Cells (August 2020)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium
Article in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (June 2020)
Exogenous Galactosylceramide as Potential Treatment for CLN3 Disease
Article in Annals of Neurology (August 2019)